-
Crunch time for US supplements in the EU?
29 November 2017
Skyrocketing rate of EU ‘safety’ alerts provides key tool to protect pharma interest
-
Yes to Life starts cancer conversation in London
29 November 2017
Avoiding the treatment conveyor belt - exploring ways to integrate conventional and lifestyle cancer care
-
Most new ‘breakthrough’ cancer drugs don’t work
01 November 2017
Why the drug licensing system needs to be overhauled and properly communicated to the public